Impact of evidence-based stroke care on patient outcomes: a multilevel analysis of an international study by Muñoz-Venturelli, Paula et al.
Article
Impact of evidence­based stroke care on patient 
outcomes: a multilevel analysis of an international 
study
Muñoz-Venturelli, Paula, Li, Xian, Middleton, Sandy, Watkins, 
Caroline Leigh, Lavados, Pablo M., Olavarría, Verónica V., Brunser, 
Alejandro, Pontes-Neto, Octavio, Santos, Taiza E. G., Arima, 
Hisatomi, Billot, Laurent, Hackett, Maree, Strong, Lily, Robinson, 
Thomson and Anderson, Craig S.
Available at http://clok.uclan.ac.uk/28947/
Muñoz­Venturelli, Paula, Li, Xian, Middleton, Sandy, Watkins, Caroline Leigh ORCID: 0000­
0002­9403­3772, Lavados, Pablo M., Olavarría, Verónica V., Brunser, Alejandro, Pontes­Neto, 
Octavio, Santos, Taiza E. G. et al (2019) Impact of evidence­based stroke care on patient 
outcomes: a multilevel analysis of an international study. Journal of the American Heart 
Association, 8 (13).  
It is advisable to refer to the publisher’s version if you intend to cite from the work.
For more information about UCLan’s research in this area go to 
http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>.
For information about Research generally at UCLan please go to 
http://www.uclan.ac.uk/research/ 
All outputs in CLoK are protected by Intellectual Property Rights law, including
Copyright law.  Copyright, IPR and Moral Rights for the works on this site are retained 
by the individual authors and/or other copyright owners. Terms and conditions for use 
of this material are defined in the http://clok.uclan.ac.uk/policies/
CLoK
Central Lancashire online Knowledge
www.clok.uclan.ac.uk
Impact of Evidence-Based Stroke Care on Patient Outcomes:
A Multilevel Analysis of an International Study
Paula Mu~noz Venturelli, MD, PhD; Xian Li, PhD; Sandy Middleton, PhD; Caroline Watkins, PhD; Pablo M. Lavados, MD, MPH;
Veronica V. Olavarrıa, MD, MSc; Alejandro Brunser, MD; Octavio Pontes-Neto, MD, PhD; Taiza E. G. Santos, PhD; Hisatomi Arima, MD, PhD;
Laurent Billot, MRes; Maree L. Hackett, PhD; Lily Song, MD, PhD; Thompson Robinson, MD; Craig S. Anderson, MD, PhD; on behalf of the
HEADPOST (Head Positioning in Acute Stroke Trial) Investigators*
Background-—The uptake of proven stroke treatments varies widely. We aimed to determine the association of evidence-based
processes of care for acute ischemic stroke (AIS) and clinical outcomeof patientswho participated in theHEADPOST (Head Positioning
in Acute Stroke Trial), a multicenter cluster crossover trial of lying ﬂat versus sitting up, head positioning in acute stroke.
Methods and Results-—Use of 8 AIS processes of care were considered: reperfusion therapy in eligible patients; acute stroke unit
care; antihypertensive, antiplatelet, statin, and anticoagulation for atrial ﬁbrillation; dysphagia assessment; and physiotherapist
review. Hierarchical, mixed, logistic regression models were performed to determine associations with good outcome (modiﬁed
Rankin Scale scores 0–2) at 90 days, adjusted for patient and hospital variables. Among 9485 patients with AIS, implementation of
all processes of care in eligible patients, or “defect-free” care, was associated with improved outcome (odds ratio, 1.40; 95% CI,
1.18–1.65) and better survival (odds ratio, 2.23; 95% CI, 1.62–3.09). Defect-free stroke care was also signiﬁcantly associated with
excellent outcome (modiﬁed Rankin Scale score 0–1) (odds ratio, 1.22; 95% CI, 1.04–1.43). No hospital characteristic was
independently predictive of outcome. Only 1445 (15%) of eligible patients with AIS received all processes of care, with signiﬁcant
regional variations in overall and individual rates.
Conclusions-—Use of evidence-based care is associated with improved clinical outcome in AIS. Strategies are required to address
regional variation in the use of proven AIS treatments.
Clinical Trial Registration-—URL: https://www.clinicaltrials.gov. Unique Identiﬁer: NCT02162017. ( J Am Heart Assoc. 2019;8:
e012640. DOI: 10.1161/JAHA.119.012640.)
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S troke is a major cause of death and disability, especially inlow-resource regions.1 Although considerable advances
have been made in generating the evidence base that supports
various treatments, particularly for acute ischemic stroke (AIS),
their implementation is often limited by resource, organiza-
tional, and funding barriers in clinical practice.2 For example,
acute stroke unit (ASU) care is one of the most cost-effective
treatments,3–5 butmany hospitals around theworld do not have
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such a service or only have it organized in a partial manner.6
Improvements in the delivery of stroke care can translate into
better patient outcomes, but most “real-life” quality-of-care
evaluations are undertaken in well-resourced hospitals located
in high-income countries and without necessarily considering
both organizational and patient variables.7,8 A better under-
standing of variations in the processes of care in relation to
patient outcomes can help prioritize efforts toward improving
the implementation of evidence, especially in low- and middle-
income countries.9,10
In a previous report, we identiﬁed large variations in the
organization of stroke care (ie, stafﬁng, protocols, and
discharge planning) across hospitals in different countries
in establishing the network for the international, multicenter
HEADPOST (Head Positioning in Acute Stroke Trial).11 More
research is needed on the impact of gaps in evidence-based
care in low- and middle-income countries, where access to
ASU care, let alone other therapies, is often limited.12 We
aimed to determine the association between the use of
recommended evidence-based processes of stroke care and
clinical outcomes for patients with AIS who participated in
HEADPOST using analyses to account for hospital and patient
characteristics.
Methods
The data that support the ﬁndings of this study are available
through a formal protocol request from researchers to the
Research Ofﬁce of The George Institute Australia via the
corresponding author.
Design
HEADPOST was an international, multicenter, cluster-rando-
mized, crossover trial with centralized outcome assessment,
the details of which are outlined elsewhere.13,14 In brief, the
trial used a pragmatic design with broad eligibility and
assessment criteria, to facilitate the recruitment of 11 093
adult patients with a clinical diagnosis of acute stroke (AIS or
intracerebral hemorrhage) to determine the effectiveness of
lying ﬂat (0°) compared with sitting up (≥30°) head position-
ing, applied within the ﬁrst 24 hours of admission at 114
hospitals in 9 countries, during 2016 to 2017. Patients were
eligible for inclusion in the trial if they were aged ≥18 years,
presented to the emergency department or an inpatient
service at a participating center, and received a clinical
diagnosis of acute stroke. Patients were excluded if the local
clinician-investigator considered that the assigned head
position could not be maintained consistently, if the con-
ﬁrmed diagnosis was a transient ischemic attack, or if the
patient declined to participate in the trial. Patients were also
excluded if there was a clear indication for, or contraindication
to, either of the head positions.13 Local investigators were
required to recruit a prespeciﬁed target (cluster) number of
consecutive patients into an initial randomized head position
that was implemented as a usual standard-of-care policy
before the service was crossed over for the other randomized
head position to be implemented as a similar standard-of-care
policy. The protocol was approved by all regulatory authorities
and ethics committees at participating hospitals. A senior
executive ofﬁcer at each hospital acted as a “guardian” (as
part of the cluster-randomized trial design) and provided
consent at an institutional level for head positioning to be
implemented as a “low-risk intervention” to clusters of
patients as part of routine care; written informed consent
was subsequently obtained from patients (or their approved
surrogates) for the collection of medical data and participation
in follow-up assessments. The corresponding author has full
access to all the data in the study and takes responsibility for
their integrity and the data analysis.
To assist the implementation of the intervention at each
site, data were gathered on the organization of the hospital
and in the wards involved in implementing the randomized
interventions. After a baseline assessment that included
collecting demographic, medical history, and clinical informa-
tion on the severity of the neurological deﬁcit, according to
the National Institutes of Health Stroke Scale and vital signs,
adherence to the allocated head position was monitored in
patients over the subsequent 24 hours. Further follow-up data
were collected on the management of patients at the time of
separation (day 7 or at hospital discharge, transfer, or death,
if earlier) and all serious adverse events, including death, until
90 days. Appropriately trained outcome assessors in a central
ofﬁce, who were kept blind to the management of patients,
used a script to conduct a telephone assessment of health
and physical functioning at 90 days. The key clinical outcome
was the degree of disability, according to the modiﬁed Rankin
Clinical Perspective
What Is New?
• Adherence to evidence-based care was associated with
improved outcomes in patients with ischemic stroke who
participated in the large pragmatic trial HEADPOST (Head
Positioning in Acute Stroke Trial).
• However, there was signiﬁcant variation in the amount of
evidence-based care across regions, and few patients
received the entire range (optimal treatment) of such
performance indicators.
What Are the Clinical Implications?
• There is considerable opportunity to increase the uptake of
evidence-based care in ischemic stroke to improve clinical
outcomes from this serious condition.
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Scale (mRS) score.15 Main study results showed that disability
outcomes after acute stroke did not differ signiﬁcantly
between patients assigned to a lying-ﬂat position for 24 hours
and patients assigned to a sitting-up position with the head
elevated to at least 30° for 24 hours.13
Statistical Analysis
Only patients with AIS were included in these analyses.
Comparisons of categorical and continuous variables were
assessed with the v2 and Wilcoxon Mann-Whitney rank sum
tests, respectively. Univariable analyses were used to evaluate
associations between patient characteristics and process-of-
care indicators with 90-day clinical outcomes. Multilevel
logistic regression models were used to examine the associ-
ations between processes of care implemented in the ﬁrst
week (by day 7 or at discharge, if earlier) on good outcome
(mRS score 0–2). The following processes of care were
considered independent variables: (1) use of intravenous
recombinant tPA (tissue-type plasminogen activator) or
endovascular clot retrieval in patients who presented at the
hospital within 4.5 hours of symptom onset; (2) admission to
an ASU; use of (3) antihypertensive, (4) antiplatelet, (5) statin,
and (6) anticoagulation therapy in those with evidence of atrial
ﬁbrillation/ﬂutter (AF); (7) receipt of a dysphagia screen and/
or assessment before feeding was commenced; and (8)
assessment by a physiotherapist in patients with residual
disability (mRS score 3–5 on day 7). A composite variable of
early “defect-free” care (including the aforementioned 8
independent processes of care) was constructed to identify
the proportion of eligible patients who received all applicable
processes of care. A hierarchical mixed logistic regression with
ﬁxed period, ﬁxed head position effect, random cluster, and
random cluster-period effects, plus the variable for evidence-
based care, was used as the base model. Three sequential
models were constructed to adjust for other patient- and
hospital-level characteristic associations with patient out-
comes. Variables were treated as independent variables.
Association between defect-free care and excellent outcome
(90-day mRS score 0–1) was also evaluated.
Consistency of treatment effect across prespeciﬁed sub-
groups (deﬁned by age, sex, major country/region groupings,
baseline National Institutes of Health Stroke Scale score, and
pathologic subtype of AIS) was assessed by means of tests for
interaction. Sensitivity analyses included the use of multiple
imputation because >10% of observations for mRS scores
were missing at 90 days16 and exclusion of those who had
died within the ﬁrst 7 days after admission.
To analyze the association between patients’ outcome and
hospital characteristics, univariable analyses were performed
using hierarchical mixed logistic regression models, as
previously described, taking account of the cluster crossover
study design. Multivariable analyses included adjustment for
patient characteristics that had the potential to inﬂuence
recovery: age, sex, history of hypertension, stroke, heart
disease or diabetes mellitus, premorbid estimated mRS
score, baseline National Institutes of Health Stroke Scale
score, time from symptom onset to commencement of the
intervention, and country. Adjustment variables were selected
for potential clinical signiﬁcance as well as statistical
signiﬁcance on initial univariable analyses. Data are reported
with 2-sided P values, without adjustment for multiple
comparisons, and as odds ratios with 95% CIs. All analyses
were undertaken with SAS software, version 9.3 (SAS
Institute).
Role of the Funding Source
The study sponsor was not involved in the study design or
collection, analysis, and interpretation of data; and had no role
in the writing of this report or in the decision to submit the
manuscript for publication.
Results
There were 9485 patients with AIS included in analyses
(Figure 1). Table 1 shows that patients with AIS who received
defect-free stroke care had more risk factors, lower levels of
premorbid disability, and greater baseline neurological impair-
ment, compared with those who did not receive defect-free
stroke care. Defect-free care was more frequent in hospitals
in Australia and the United Kingdom, in those with lower
numbers of stroke admissions per annum, in nonacademic
hospitals, and in those where speciﬁc protocols for stroke
care were in place and where multidisciplinary teams were
involved in usual care.
Table 2 shows the results of multilevel modeling: use of
antiplatelets, use of statins, dysphagia screen, and physio-
therapy assessment were associated with better clinical
outcome. The use of standard reperfusion treatment (re-
combinant tPA or endovascular clot retrieval within the ﬁrst
4.5 hours of symptoms onset) was also associated with
better disability-free survival after adjusting for patient and
hospital characteristics. Early implementation of all stroke
care eligible processes of care was associated with greater
likelihood of good clinical outcome (odds ratio, 1.40; 95% CI,
1.18–1.65). When the outcome considered was mRS score 0
to 1, the association between early implementation of
defect-free care and greater likelihood of excellent outcome
(mRS score 0–1) remained signiﬁcant (odds ratio, 1.22; 95%
CI, 1.04–1.43). These results were further conﬁrmed in
sensitivity analyses with multiple imputations for missing
primary outcome data (Table S1) by excluding patients with
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early death (Table 2), and after excluding patients who
received reperfusion therapy and anticoagulation for AF
(Table 2). In terms of survival at 90 days, multilevel modeling
showed that use of all processes of care was associated with
better survival (odds ratio, 2.23; 95% CI, 1.62–3.09)
(Table S2).
Overall, use of the AIS processes of care was low (1445/
9485, 15.2%) and varied widely across regions, being highest
in Australia/United Kingdom (1001/3850, 26.0%) and India/
Sri Lanka (151/658, 22.9%), intermediate in South America
(122/691, 15.2%), and lowest in China (171/4178, 4.1%)
(P<0.001) (Table S3). Those components with the greatest
regional differences were ASU admission, use of antihyper-
tensive therapy, anticoagulation for AF, and physiotherapy
assessment. There was consistency in the beneﬁcial associ-
ations across patient subgroups (Figures 2 and 3), but no
hospital characteristic was independently predictive of clinical
outcome (Table S4).
Discussion
These secondary analyses of a large international clinical trial
have 2 major ﬁndings. First, data show that the implementation
of guideline-recommended AIS processes of care is associated
with clear beneﬁcial clinical outcome, including a dramatic
halving in the risk of death within 90 days, even after
accounting for a range of confounding variables. Second,
overall use of defect-free stroke care was low, and there was
considerable regional variation, especially across several com-
ponents, including the use of ASU care. Although the organi-
zation of services is important for delivering efﬁcient and
effective stroke care, we were unable to identify a speciﬁc
hospital characteristic that was independently associated with
clinical outcome; patient-level characteristics were the main
driver of clinical outcome.
Various stroke quality assessment and improvement
programs exist around the world. In the United States, for
example, the Centers for Disease Control and Prevention
monitors adherence to 10 quality-of-care measures in hospi-
tals across 7 states through the Paul Coverdell National Acute
Stroke Registry, where patients who received the best quality
of care have been shown to have an increased chance of long-
term survival.8 Quality of care and process improvement have
also been presented in numerous publications from the
American Heart Association’s Get With The Guidelines
program.17 Similar initiatives have been developed in Australia
and the United Kingdom,7,18,19 but there are few available in
Figure 1. Patient ﬂow diagram.
DOI: 10.1161/JAHA.119.012640 Journal of the American Heart Association 4
Impact of Acute Stroke Care in Patient Outcome Mu~noz Venturelli et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on June 25, 2019
Table 1. Characteristics of Ischemic Stroke Patients and Hospitals, Stratiﬁed by Receipt of “Defect-Free” Evidence-Based Care
Variable
Defect-Free Care
Total (N=9485) Yes (N=1445) No (N=8040) P Value*
Patients
Age, y 69 (59–79) 72 (63–81) 68 (59–78) 0.999
Men 5759 (60.7) 826 (57.2) 4933 (61.4) 0.914
Hypertension 6141 (64.9) 1154 (80.0) 4987 (62.2) <0.001
Prior stroke 2258 (23.9) 280 (19.4) 1978 (24.7) 0.826
Coronary artery disease 1339 (14.2) 250 (17.4) 1089 (13.6) 0.002
Atrial fibrillation 1059 (11.2) 106 (7.4) 953 (11.9) <0.001
Heart failure 358 (3.8) 57 (4.0) 301 (3.8) 0.184
Diabetes mellitus 2354 (24.9) 451 (31.3) 1903 (23.7) <0.001
Tobacco use 1924 (20.5) 241 (16.8) 1683 (21.2) 0.917
Aspirin or other antiplatelet use 5182 (54.7) 677 (46.9) 4505 (56.1) <0.001
Anticoagulant use 824 (8.7) 86 (6.0) 738 (9.2) <0.001
Premorbid function on the mRS
0 (No symptoms) 5800 (61.3) 968 (67.1) 4832 (60.2) 0.012
1 (No significant disability) 1691 (17.9) 214 (14.8) 1477 (18.4) . . .
2 (Slight disability) 998 (10.5) 125 (8.7) 873 (10.9) . . .
3 (Moderate disability) 598 (6.3) 93 (6.4) 505 (6.3) . . .
4 (Moderate/severe disability) 306 (3.2) 32 (2.2) 274 (3.4) . . .
5 (Severe disability) 76 (0.8) 11 (0.8) 65 (0.8) . . .
Admission NIHSS score 4 (2–8) 4 (2–8) 4 (2–8) <0.001
Symptom onset to intervention, h 14 (5–37) 16 (7–33) 14 (5–39) <0.001
Initial head position lying flat 4532 (47.8) 685 (47.4) 3847 (47.8) 0.770
Region of recruitment
Australia/United Kingdom 3850 (40.6) 1001 (69.3) 2849 (35.4) <0.001
China, including Taiwan 4178 (44.0) 171 (11.8) 4007 (49.8) . . .
India and Sri Lanka 658 (6.9) 151 (10.4) 507 (6.3) . . .
South America 799 (8.4) 122 (8.4) 677 (8.4) . . .
Hospitals
No. of stroke patients annually
<500 2252 (24.1) 442 (30.6) 1810 (22.9) 0.010
500–1000 3642 (39.0) 673 (46.6) 2969 (37.6) . . .
>1000 3446 (36.9) 330 (22.8) 3116 (39.5) . . .
Academic teaching hospital 8094 (86.5) 1112 (77.0) 6982 (88.3) 0.007
Pathway for stroke care 8491 (90.8) 1416 (98.0) 7075 (89.5) <0.001
Protocols for fever/blood glucose/swallow 7043 (75.3) 1088 (75.3) 5955 (75.3) 0.899
ED protocols 8847 (94.6) 1309 (90.6) 7538 (95.3) 0.256
Multidisciplinary teams 5561 (59.5) 1170 (81.0) 4391 (55.5) <0.001
Endovascular clot retrieval 5305 (57.4) 685 (48.8) 4620 (58.9) 0.042
Data are given as number (percentage) or median (interquartile range). ED indicates emergency department; mRS modiﬁed Rankin Scale; NIHSS, National Institutes of Health Stroke Scale.
*P values from unadjusted hierarchical mixed logistic regression model, with link function being logit with ﬁxed period, ﬁxed head position effect, random cluster, and random cluster-
period effects.
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developing countries.20 In keeping with our ﬁndings of the
cumulative beneﬁt on outcomes from multiple processes of
care, data from the Australian Stroke Clinical Registry have
shown that patients who received 3 processes of care (stroke
unit care, discharged on antihypertensive agents, and dis-
charged with a care plan) had a 70% reduced hazard of death
at 180 days.18
Within the various processes of care analyzed, reperfusion
treatment and ASU care showed the greatest variations
across the participating countries in our study, despite being
recognized as those with the largest beneﬁt. As a time-critical
treatment, use of intravenous thrombolysis is often restricted
by local barriers, such as system networks and patient
awareness of disease, resulting in early emergency consulta-
tion. For example, fewer patients receive recombinant tPA
when arriving within 4 hours of symptom onset (39%),21
compared with those arriving within 2 hours (88%).22 Another
consideration to be made is about stroke care performance
and admission volume because our ﬁndings are opposed to
the usual assumption that practice improves processes of
care. This might have been related to overwhelming clinical
volumes in larger hospitals, mostly from the Asian region.
We recognize that the deﬁnitions and timing of defect-free
stroke care treatments may vary,21,22 as is the case for
anticoagulation in those with AF and the initiation of
antihypertensive treatment after AIS. Although current guide-
lines recommend initiation of anticoagulation within 2 weeks
of a cardioembolic stroke, except for patients with large
infarcts or other risk factors for hemorrhage,23 timing for
treatment initiation after the onset of AIS presents high
variability in practice. On the other hand, there is global
consensus on the use of blood pressure–lowering treatment
in patient candidates for acute reperfusion therapy and in
patients not receiving reperfusion therapy but with severe
Figure 2. “Defect-free” stroke care and good outcome (modiﬁed Rankin Scale [mRS] scores 0–2) at 90 days, by subgroups. AIS indicates
acute ischemic stroke; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio.
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hypertension.24 Early commencement of antihypertensive
therapy in patients with milder hypertension is subjected to
more debate, although it appears to be safe and reasonable to
improve long-term blood pressure control, unless contraindi-
cated. Although we have shown that the initiation of
anticoagulation and blood pressure lowering within 7 days
was related to higher survival after AIS, there is the potential
for this to reﬂect indication bias, whereby the treating
clinician could have commenced the treatment earlier in
those considered at low risk of complications and clinically
stable.
Even after excluding the use of thrombolysis and
thrombectomy, which can be more complex and dependent
on speciﬁc time frames, and anticoagulation for AF, where
early initiation is debatable, we have shown that defect-free
treatment was only applied in approximately one ﬁfth of
patients from this international cohort, revealing an alarming
gap in guideline-directed treatment. Direct comparison with
other studies is limited by use of different criteria; however,
an audit of UK hospitals revealed 46% of patients with AIS
received good quality treatment in the ﬁrst 72 hours.19 The
latter considered different quality criteria, including brain
scan; early evaluation by stroke consultant or associate
specialist, nurse, and therapists; swallow evaluation; admis-
sion to stroke unit; antiplatelet use; and ﬂuid/nutrition.
When individual processes of care are compared, results are
similar to our ﬁndings on swallow assessment, ASU, and
antiplatelets use.19 In a recent report from INTERSTROKE (a
case-control study of the global and regional effects of
potentially modiﬁable risk factors associated with acute
stroke in 32 countries), use of thrombolysis, antiplatelets,
and statins was lower in comparison to our results, and
higher for blood pressure lowering.12 Moreover, the authors
showed that patients enrolled from hospitals in low- and
Figure 3. Impact in 90-day mortality of “defect-free” stroke care in different prespeciﬁed subgroups. AIS indicates acute ischemic stroke;
NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio.
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middle-income countries had poorer access to investiga-
tions, treatments, and services compared with those
enrolled from hospitals in high-income countries. In line
with our results, these patients had worse clinical outcomes,
which could only be partly explained by the inclusion of
patients with more severe stroke. These ﬁndings highlight
the importance of widespread implementation of stroke
processes of care, particularly across low-resource areas,
where they are still scarce.
As stroke is a national priority in China, the central
government has initiated a program of quality improvement
strategies that include screening for high-risk individuals in
the community, process-of-care performance measures, and
organizational development to improve stroke care.25 Multi-
faceted initiatives have been shown to improve adherence to
performance measures in Chinese hospitals, but were not
able to show signiﬁcant change in the defect-free stroke
care.26 Accordingly, our data reemphasize the importance of
quality improvement initiatives in China.
To our knowledge, this is the ﬁrst study to assess the
impact of using multiple evidence-based stroke care pro-
cesses on clinical outcomes in a large multinational cohort of
patients. HEADPOST was a clinical trial with broad inclusion
criteria, allowing the participation of a wide range of patients;
and the analyses herein presented were strengthened by the
use of multilevel modeling to account for patient- and hospital-
level variables. Inevitably, though, these secondary analyses of
nonrandomized processes of care are limited by the potential
for chance associations and residual confounding, as well as
broad assumption of patient eligibility for different process of
care. Interactions between different stroke care interventions
were not explored, leading to possible risk of confounding by
indication. Because the main study had 10% of missing
primary outcome data in mRS score, the decision to use
imputation for missing mRS scores is also to be acknowledged
as a limitation of the study.
In summary, in this study, we have shown, among eligible
patients with AIS, that those who received evidence-based
processes of care had better outcomes, but the overall uptake
of the suite of therapies was low across a multinational
population. Strategies to facilitate implementation of evi-
dence-based stroke care are needed, particularly in low-
resource regions.
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Table S1. Distribution of the evidence-based interventions and model analysis results for ischemic 
stroke treatment based on mRS at 3 months including multiple imputation. 
 
    Unadjusted  Model 3+MI  
Evidence-based interventions 
mRS 0-2  
(N=5112) 
mRS 3-6  
(N=3271) Total (N=8383) OR (95%CI) P value OR (95%CI) P value 
Reperfusion therapy (n=3093) 591 (34.2%) 460 (33.7%) 1051 (34.0%) 1.06 (0.91,1.25) 0.454 1.37 (1.13,1.67) 0.002 
ASU admission 2633 (51.5%) 2090 (63.9%) 4723 (56.3%) 0.77 (0.65,0.91) 0.003 1.10 (0.88,1.38) 0.396 
Antihypertensives  2771 (54.2%) 1954 (59.7%) 4725 (56.4%) 0.89 (0.81,0.98) 0.023 1.08 (0.95,1.23) 0.237 
Antiplatelet therapy 4975 (97.3%) 3088 (94.4%) 8063 (96.2%) 1.98 (1.56,2.50) <0.001 1.49 (1.12,1.99) 0.006 
Statin therapy 4390 (85.9%) 2570 (78.6%) 6960 (83.0%) 1.64 (1.45,1.87) <0.001 1.22 (1.05,1.42) 0.010 
Anticoagulation in AF (n=1203) 259 (49.7%) 315 (46.2%) 574 (47.7%) 1.14 (0.89,1.45) 0.293   
Swallow assessment 3916 (76.6%) 2363 (72.2%) 6279 (74.9%) 1.47 (1.30,1.67) <0.001 1.26 (1.08,1.46) 0.002 
Physiotherapy in disabled patients 
(n=3073) 
645 (72.5%) 1549 (71.0%) 2194 (71.4%) 1.20 (0.96,1.50) 0.102 1.41 (1.06,1.88) 0.018 
Optimal stroke care  770 (15.1%) 459 (14.0%) 1229 (14.7%) 1.45 (1.26,1.67) <0.001 1.36 (1.15,1.61) <0.001 
Optimal stroke care (without 
reperfusion/anticoagulation) 
1146 (22.4%) 795 (24.3%) 1941 (23.2%) 1.21 (1.07,1.37) 0.002 1.25 (1.08,1.45) 0.004 
        
mRS: modified Rankin scale, MI: multiple imputation, ASU: acute stroke unit, AF: atrial fibrillation 
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Table S2. Distribution of the evidence-based interventions and model analysis results for ischemic stroke treatment based on 
mortality at 3 months. 
 
    Unadjusted  Model 1  Model 2  Model 3  
Evidence-based 
interventions Alive (N=8619) Dead (N=652) Total (N=9271) OR (95%CI) P value OR (95%CI) P value OR (95%CI) P value OR (95%CI) P value 
Reperfusion 
therapy 
(n=3509) 
1110 (34.9%) 98 (29.7%) 1208 (34.4%) 1.27 (0.98,1.64) 0.069 1.05 (0.80,1.39) 0.711 1.69 (1.24,2.31) <0.001 1.72 (1.26,2.35) <0.001 
ASU admission 4985 (57.8%) 469 (71.9%) 5454 (58.8%) 0.70 (0.53,0.93) 0.013 1.40 (0.98,2.00) 0.062 1.58 (1.11,2.25) 0.011 1.69 (1.17,2.43) 0.005 
Antihypertensive 
therapy 
4891 (56.7%) 376 (57.7%) 5267 (56.8%) 1.15 (0.97,1.36) 0.111 1.42 (1.18,1.70) <0.001 1.38 (1.10,1.72) 0.004 1.38 (1.11,1.72) 0.004 
Antiplatelet 
therapy 
8342 (96.8%) 586 (89.9%) 8928 (96.3%) 3.06 (2.27,4.12) <0.001 3.13 (2.29,4.29) <0.001 1.99 (1.37,2.88) <0.001 1.98 (1.37,2.87) <0.001 
Statin therapy 7255 (84.2%) 410 (62.9%) 7665 (82.7%) 3.17 (2.64,3.81) <0.001 2.72 (2.24,3.30) <0.001 2.11 (1.70,2.62) <0.001 2.12 (1.70,2.64) <0.001 
Anticoagulation 
in AF (n=1354) † 
560 (49.5%) 92 (41.3%) 652 (48.2%) 1.35 (1.00,1.83) 0.053     -      - <0.001     - <0.001 
Swallow 
assessment  
6582 (76.4%) 403 (61.8%) 6985 (75.3%) 2.39 (1.96,2.90) <0.001 2.25 (1.84,2.74) <0.001 1.92 (1.54,2.39) <0.001 1.94 (1.55,2.42) <0.001 
Physiotherapy in 
disabled patients 
(n=3443) 
2145 (74.2%) 391 (70.7%) 2536 (73.7%) 1.52 (1.18,1.95) 0.001 2.67 (1.98,3.60) <0.001 2.29 (1.67,3.13) <0.001 2.22 (1.60,3.07) <0.001 
Optimal stroke 
care 
1368 (15.9%) 59 (9.0%) 1427 (15.4%) 2.43 (1.83,3.23) <0.001 2.45 (1.83,3.27) <0.001 2.16 (1.57,2.97) <0.001 2.23 (1.62,3.09) <0.001 
Optimal stroke 
care (without 
reperfusion/ 
anticoagulation) 
2137 (24.8%) 132 (20.2%) 2269 (24.5%) 
1.83 (1.47,2.26) <0.001 2.10 (1.68,2.62) <0.001 1.88 (1.47,2.41) <0.001 1.94 (1.51,2.49) <0.001 
Optimal stroke 
care (only 
survivors >7 
days) (n=9153) 
1368 (15.9%) 54 (10.1%) 1422 (15.5%) 2.09 (1.55,2.82) <0.001 2.13 (1.57,2.89) <0.001 1.92 (1.38,2.67) <0.001 1.95 (1.40,2.73) <0.001 
          
ASU: acute stroke unit, AF: atrial fibrillation 
Un-adjusted: hierarchical mixed logistic regression model, the link function is logit with fixed period, fixed head position effect, random cluster, and 
random cluster-period effects. 
Model 1:  Adjusted for country, prestroke mRS score, age and sex. 
Model 2:  Further adjusted for baseline NIHSS score, and previous history of stroke, heart disease, or diabetes, history of hypertension, and time 
from stroke onset to intervention. 
Model 3:  Further adjusted for # of stroke patients admitted annually, multi-discipline team available, academic hospital, local special pathway or 
service organization for stroke care, endovascular therapies available for stroke patients. 
†Results not shown because the models did not converge based on low numbers. 
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Table S3. Evidence-based interventions for ischemic stroke treatment and optimal treatment 
stratified by region. 
 
Evidence-based interventions 
 
Australia and UK
  
(N=3850) 
China and 
Taiwan  
(N=4178) 
India and Sri 
Lanka  
(N=658) 
South America  
(N=799) 
Total  
(N=9485) P value 
Reperfusion therapy 810 (37.7%) 215 (25.3%) 56 (29.9%) 142 (37.6%) 1223 (34.3%) <0.001 
ASU admission 3785 (98.3%) 855 (20.5%) 560 (85.1%) 336 (42.1%) 5536 (58.4%) <0.001 
Antihypertensives therapy 2661 (69.1%) 1788 (42.8%) 383 (58.2%) 533 (66.7%) 5365 (56.6%) <0.001 
Antiplatelet therapy 3681 (95.6%) 4041 (96.7%) 632 (96.0%) 777 (97.2%) 9131 (96.3%) 0.026 
Statin therapy 2908 (75.5%) 3621 (86.7%) 561 (85.3%) 750 (93.9%) 7840 (82.7%) <0.001 
Anticoagulation in AF 457 (46.9%) 102 (37.4%) 28 (77.8%) 78 (84.8%) 665 (48.4%) <0.001 
Swallow assessment 3226 (83.8%) 2865 (68.6%) 438 (66.6%) 607 (76.0%) 7136 (75.2%) <0.001 
Physiotherapy in disabled 
patients 
1718 (94.9%) 346 (34.1%) 207 (63.1%) 314 (83.5%) 2585 (73.3%) <0.001 
Optimal stroke care 1001 (26.0%) 171 (4.1%) 151 (22.9%) 122 (15.3%) 1445 (15.2%) <0.001 
       
ASU: acute stroke unit, AF: atrial fibrillation 
P value from logistic regression model 
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Table S4. Patient outcome by hospital characteristics: uni and multivariable logistic regression adjusted for 
patient characteristics. 
 
 Univariable analysis  Multivariable analysis 
Hospital characteristics 
mRS 0-2 
(N=5112) 
mRS 3-6 
(N=3271) 
Total 
(N=8383) 
OR 
(95%CI) P value 
 mRS 0-2 
(N=4931) † 
mRS 3-6 
(N=3068) † 
Total 
(N=7999) † 
OR 
(95%CI) P value 
Number of stroke patients 
admitted annually 
           
   <500 1133 (22.6%) 887 (27.5%) 2020 (24.5%)    1100 (22.7%) 836 (27.6%) 1936 (24.6%)   
   [500,1000] 1792 (35.7%) 1343 (41.6%) 3135 (38.0%) 1.10 (0.84,1.44)   1718 (35.5%) 1269 
(42.0%) 
2987 (38.0%) 0.96 (0.74,1.24)  
   >1000 2092 (41.7%) 995 (30.9%) 3087 (37.5%) 1.87 (1.41,2.47) <0.001  2019 (41.7%) 920 (30.4%) 2939 (37.4%) 1.12 (0.84,1.50) 0.421 
Academic hospital 4461 (88.9%) 2737 (84.6%) 7198 (87.2%) 1.36 (0.98,1.88) 0.067  4321 (89.3%) 2563 
(84.6%) 
6884 (87.5%) 1.02 (0.77,1.36) 0.882 
Local special pathway or service 
organisation for stroke care 
4459 (88.8%) 2990 (92.5%) 7449 (90.2%) 0.76 (0.51,1.13) 0.176  4290 (88.7%) 2795 
(92.2%) 
7085 (90.0%) 1.19 (0.85,1.65) 0.316 
Local protocols for fever/blood 
glucose/swallow dysfunction 
3828 (76.3%) 2355 (72.8%) 6183 (74.9%) 1.22 (0.93,1.61)) 0.149  3697 (76.4%) 2201 
(72.6%) 
5898 (74.9%) 1.04 (0.84,1.29) 0.703 
Organized ED clinical 
pathway/checklist/protocols for 
evaluation 
4790 (95.4%) 3029 (93.7%) 7819 (94.7%) 1.46 (0.89,2.38) 0.130  4621 (95.5%) 2853 
(94.1%) 
7474 (95.0%) 1.20 (0.78,1.83) 0.404 
Availability of a local 
multidisciplinary team 
2675 (53.3%) 2114 (65.4%) 4789 (58.0%) 0.60 (0.48,0.76) <0.001  2571 (53.1%) 1980 
(65.3%) 
4551 (57.8%) 0.80 (0.62,1.05) 0.106 
Endovascular therapies available 
for stroke patients 
2955 (59.3%) 1774 (55.5%) 4729 (57.8%) 1.22 (0.95,1.55) 0.112  2869 (59.7%) 1671 
(55.7%) 
4540 (58.2%) 1.22 (0.95,1.55) 0.270 
            
†: Only patients with all non-missing covariates 
mRS: modified Rankin Scale, ED: emergency department 
Univariable analysis: hierarchical mixed logistic regression model, the link function is logit, with fixed period, fixed head 
position effect, random cluster, and random cluster-period effects. 
Multivariable analysis:  Adjusted for age, sex, previous history of stroke, heart disease, or diabetes, history of 
hypertension, prestroke mRS score, baseline NIHSS score, time from stroke onset to intervention and country. 
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